Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil,
once daily (QD), co-administered with chlorthalidone in treating individuals with essential
hypertension, compared to treatment with chlorthalidone alone.